Home  >  Products  >  MEFV (Mediterranean fever) Blocking Peptide (the N terminal of protein) (100ug)
MEFV (Mediterranean fever) Blocking Peptide (the N terminal of protein) (100ug)

MEFV (Mediterranean fever) Blocking Peptide (the N terminal of protein) (100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-MEFV antibody (Catalogue #: ARP37973_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP37973
Size: 100 ug
Weight: 86kDa
Gene: 4210
Format: Lyophilized powder
Target: MEFV was identified as the gene that when mutated causes Mediterranean fever, a hereditary periodic fever syndrome. MEFV is expressed in granulocytes and myeloid bone marrow precursors. This gene encodes a protein, also known as pyrin or marenostrin, that is an important modulator of innate immunity. Mutations in this gene are associated with Mediterranean fever, a hereditary periodic fever syndrome. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
Alternative names: FMF; MEF; MGC126560; MGC126586; TRIM20